gut
ME
ta
G
enome
A
tlas
Home
Browse
Search
Download
Help
About
Citation
LZX Lab
Introduction
Databases
dbEBV
dbRicePro
gutMEGA
iHypoxia
iCysMod
qPhos
qPTM
Tools
cPhosBac
DeepCalpain
DeepGSH
Deep-PLA
DrugCVar
dSCOPE
pCysMod
prkC-PSP
Result
taxon like '%g__Haemophilus%'
Search content: Taxon = Haemophilus
There are 332 entries with your keyword(s).
Condition
70-79 years / 10-19 years
70-79 years / 20-29 years
70-79 years / 30-39 years
70-79 years / 4-9 years
70-79 years / 40-49 years
70-79 years / 50-59 years
70-79 years / 60-69 years
70-79 years / Preweaning
70-79 years / Weaned-3 years
70-79 years / Weaning
80-89 years / 70-79 years
90-99 years / 70-79 years
> 100 years / 70-79 years
Adenomas / Normal
Adult control / Pediatric control
Advanced conventional adenoma / Normal
Alcoholic liver disease / Alcohol dependence syndrome
Amyotrophic lateral sclerosis / Normal
Animal-based diet / Plant-based diet
Anti-islet cell autoantibodies, Developed / Remained negative
Antibiotics, No exposure / Chronic exposure
Asymptomatic C. difficile carriers / C. difficile infection
Asymptomatic C. difficile carriers / Normal
Atherosclerotic cardiovascular disease / Normal
Breast-fed / Placebo formula
C. difficile infection / Donor
C. difficile infection / Normal
Caesarean section, Full-term / Pre-term
Children with PZQ, 1.1-2 years / 0-1 years
Children with PZQ, 10.1-13 years / 0-1 years
Children with PZQ, 10.1-13 years / 1.1-2 years
Children with PZQ, 10.1-13 years / 2.1-3 years
Children with PZQ, 10.1-13 years / 3.1-4 years
Children with PZQ, 10.1-13 years / 4.1-5 years
Children with PZQ, 10.1-13 years / 5.1-6 years
Children with PZQ, 10.1-13 years / 6.1-7 years
Children with PZQ, 10.1-13 years / 7.1-8 years
Children with PZQ, 10.1-13 years / 8.1-9 years
Children with PZQ, 10.1-13 years / 9.1-10 years
Children with PZQ, 2.1-3 years / 0-1 years
Children with PZQ, 2.1-3 years / 1.1-2 years
Children with PZQ, 3.1-4 years / 0-1 years
Children with PZQ, 3.1-4 years / 1.1-2 years
Children with PZQ, 3.1-4 years / 2.1-3 years
Children with PZQ, 4.1-5 years / 0-1 years
Children with PZQ, 4.1-5 years / 1.1-2 years
Children with PZQ, 4.1-5 years / 2.1-3 years
Children with PZQ, 4.1-5 years / 3.1-4 years
Children with PZQ, 5.1-6 years / 0-1 years
Children with PZQ, 5.1-6 years / 1.1-2 years
Children with PZQ, 5.1-6 years / 2.1-3 years
Children with PZQ, 5.1-6 years / 3.1-4 years
Children with PZQ, 5.1-6 years / 4.1-5 years
Children with PZQ, 6.1-7 years / 0-1 years
Children with PZQ, 6.1-7 years / 1.1-2 years
Children with PZQ, 6.1-7 years / 2.1-3 years
Children with PZQ, 6.1-7 years / 3.1-4 years
Children with PZQ, 6.1-7 years / 4.1-5 years
Children with PZQ, 6.1-7 years / 5.1-6 years
Children with PZQ, 7.1-8 years / 0-1 years
Children with PZQ, 7.1-8 years / 1.1-2 years
Children with PZQ, 7.1-8 years / 2.1-3 years
Children with PZQ, 7.1-8 years / 3.1-4 years
Children with PZQ, 7.1-8 years / 4.1-5 years
Children with PZQ, 7.1-8 years / 5.1-6 years
Children with PZQ, 7.1-8 years / 6.1-7 years
Children with PZQ, 8.1-9 years / 0-1 years
Children with PZQ, 8.1-9 years / 1.1-2 years
Children with PZQ, 8.1-9 years / 2.1-3 years
Children with PZQ, 8.1-9 years / 3.1-4 years
Children with PZQ, 8.1-9 years / 4.1-5 years
Children with PZQ, 8.1-9 years / 5.1-6 years
Children with PZQ, 8.1-9 years / 6.1-7 years
Children with PZQ, 8.1-9 years / 7.1-8 years
Children with PZQ, 9.1-10 years / 0-1 years
Children with PZQ, 9.1-10 years / 1.1-2 years
Children with PZQ, 9.1-10 years / 2.1-3 years
Children with PZQ, 9.1-10 years / 3.1-4 years
Children with PZQ, 9.1-10 years / 4.1-5 years
Children with PZQ, 9.1-10 years / 5.1-6 years
Children with PZQ, 9.1-10 years / 6.1-7 years
Children with PZQ, 9.1-10 years / 7.1-8 years
Children with PZQ, 9.1-10 years / 8.1-9 years
China, After 2 weeks / Baseline
China, Urban / Rural
Chronic periodontitis / Gingivitis
Chronic periodontitis / Periodontal health
Clostridia phase / Bacilli phase
Clostridia phase / Gammaproteobacteria phase
Colorectal adenoma / Normal
Colorectal cancer / Normal
Consensus molecular subtypes 2 / Consensus molecular subtypes 1
Consensus molecular subtypes 3 / Consensus molecular subtypes 1
Consensus molecular subtypes 3 / Consensus molecular subtypes 2
Constipated after lubiprostone / Normal
Constipated before lubiprostone / Normal
Coronary artery disease / Normal
Crohn's disease / Normal
Crohn's disease / Ulcerative colitis
Crohn's disease Active / Normal
Crohn's disease active onset / Normal
Crohn's disease Active presurgery / Normal
Crohn's disease induction of remission treatments, Responders / Non-responders
Crohn's disease moderate / Normal
Crohn's disease severe / Normal
Crohn's disease, Active / Active onset
Crohn's disease, Active presurgery / Active
Crohn's disease, Active presurgery / Active onset
Diarrheal Phase 2 / Diarrheal Phase 1
Diarrheal Phase 3 / Diarrheal Phase 1
Diarrheal Phase 4 / Diarrheal Phase 1
During the first ciprofloxacin course / Before ciprofloxacin
During the first week post-first ciprofloxacin / Before ciprofloxacin
During the first week post-second ciprofloxacin / Before ciprofloxacin
During the second ciprofloxacin course / Before ciprofloxacin
Formula-fed / Breast-fed
Full-term, Caesarean section / Spontaneous vaginally delivered
Gammaproteobacteria phase / Bacilli phase
Gingivitis / Periodontal health
High gene count / Low gene count
HIV, CD4 > 200 / CD4 < 200
HIV, Men sex with men / Non-men sex with men
HIV, Negative / CD4 < 200
Human Microbiome Project participants / Korean twins
In the interim period between ciprofloxacin courses / Before ciprofloxacin
Infant 1 month / Mother 1 week prior to delivery
Infant 1 week / Mother 1 week prior to delivery
Infant 1 year / Mother 1 week prior to delivery
Infant 3 months / Mother 1 week prior to delivery
Infant 7 months / Mother 1 week prior to delivery
Infants 2 months, Anthroposophic / Non-anthroposophic
Infants 3 weeks, Anthroposophic / Non-anthroposophic
Infants 6 days, Anthroposophic / Non-anthroposophic
Infants 6 months, Anthroposophic / Non-anthroposophic
Infants, 1 week / 4 weeks
Infants, 4 weeks / 8 weeks
Inpatient / Pediatric control
Intervention formula / Placebo formula
Lactobacillus casei Zhang, 28 days / 0 day
Lactobacillus casei Zhang, 42 days / 0 day
Lactobacillus casei Zhang, 42 days / 28 days
Madagascar / Central African Republic
Mother 1 year after delivery / Mother 1 week prior to delivery
Multiple kidney stones / Normal
Multiple sclerosis / Normal
Multiple sclerosis treated / Normal
Multiple sclerosis untreated / Normal
Necrotizing enterocolitis / Normal
Non-advanced conventional adenoma / Normal
Obese / Normal
Obese patients underwent Roux-en-Y gastric bypass, 1 year / Baseline
Obese patients underwent Roux-en-Y gastric bypass, 3 months / Baseline
Other colorectal conditions / Colorectal adenoma
Other colorectal conditions / Normal
Outpatient / Pediatric control
Post ciprofloxacin / Before ciprofloxacin
Post-exclusive enteral nutrition / Pre-exclusive enteral nutrition
Postmenopausal breast cancer / Normal
Pre-term, Caesarean section / Spontaneous vaginally delivered
Probiotic administration 4 weeks / Baseline
Proton pump inhibitors, After / Before
Proton pump inhibitors, After / On
Proton pump inhibitors, On / Before
Recovery Phase 2 / Recovery Phase 1
Recovery Phase 3 / Recovery Phase 1
Rheumatoid arthritis / Normal
Rio Zape-Mexico / Hinds Cave-USA
Schistosomiasis, Positive / Negative
Severely stunted / Moderately stunted
Stopping the probiotic intake 4 weeks / Probiotic administration 4 weeks
Stunted / Nonstunted
Summer / Winter
Type 1 diabetes / Normal
Type 2 diabetes / Normal
Ulcerative colitis / Normal
Ulcerative colitis with FMT / Donor
UTI patients, Adult household / Control
UTI patients, Ciprofloxacin / Control
UTI patients, Fosfomycin / Control
UTI patients, Nitrofurantoin / Control
Vibrio cholerae infected / Normal
Zonulin < 46.4 ng/mL / Zonulin > 46.4 ng/mL
Taxon level
Genus
No rank
Species
Log2Ratio
>
=
<
Filter
Download
Detail
Taxon
Condition
Log2Ratio
P
 value
k__Bacteria; p__Proteobacteria; c__Gammaproteobacteria; o__Pasteurellales; f__Pasteurellaceae; g__Haemophilus
Asymptomatic C. difficile carriers / C. difficile infection
-1.132
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Gammaproteobacteria; o__Pasteurellales; f__Pasteurellaceae; g__Haemophilus
Asymptomatic C. difficile carriers / Normal
5.083
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Gammaproteobacteria; o__Pasteurellales; f__Pasteurellaceae; g__Haemophilus
HIV, CD4 > 200 / CD4 < 200
-2.715142188
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Gammaproteobacteria; o__Pasteurellales; f__Pasteurellaceae; g__Haemophilus
HIV, Negative / CD4 < 200
-2.660117943
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Gammaproteobacteria; o__Pasteurellales; f__Pasteurellaceae; g__Haemophilus; s__Haemophilus haemoglobinophilus
Type 1 diabetes / Normal
2.012
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Gammaproteobacteria; o__Pasteurellales; f__Pasteurellaceae; g__Haemophilus; s__Haemophilus haemolyticus
Diarrheal Phase 4 / Diarrheal Phase 1
-4.465
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Gammaproteobacteria; o__Pasteurellales; f__Pasteurellaceae; g__Haemophilus; s__Haemophilus parainfluenzae
Children with PZQ, 1.1-2 years / 0-1 years
0.051
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Gammaproteobacteria; o__Pasteurellales; f__Pasteurellaceae; g__Haemophilus; s__Haemophilus parainfluenzae
Children with PZQ, 10.1-13 years / 0-1 years
-3.063
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Gammaproteobacteria; o__Pasteurellales; f__Pasteurellaceae; g__Haemophilus; s__Haemophilus parainfluenzae
Children with PZQ, 10.1-13 years / 1.1-2 years
-3.114
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Gammaproteobacteria; o__Pasteurellales; f__Pasteurellaceae; g__Haemophilus; s__Haemophilus parainfluenzae
Children with PZQ, 10.1-13 years / 2.1-3 years
-2.556
<0.001
Loading...
Showing 1 to 10 of 332 entries
,
10
20
50
100
entries per page
<
1
2
3
4
5
...
34
>